Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s):  CPHRF

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.


TSX:CPH - Post by User

Bullboard Posts
Comment by smush74on Dec 17, 2013 1:07pm
123 Views
Post# 22014420

RE:RE:RE:RE:RE:Do we move higher from here

RE:RE:RE:RE:RE:Do we move higher from here
what are you talking about or trying to say with your bank comments? This is DND...take a breather you will pop a vein. You have brought in no facts that are not open for people to find if they want to invest, you complain a lot. So I have a few questions since you seem to be all knowing. Provide a link where and when do they expect to have 50% market share, link to their application for European market or South American. I have with DND way back when the FDA first refused their patent am still with them today and will take profits when needed. I don't profess to time any ups or downs on its SP or targets. Just common sense and not get over emotional when it goes up or down.

I certainly won't beg or apologize to a whack job who thinks everybody is out to get him.
Bullboard Posts